StoxParadeep Phosphates vs Jubilant Ingrevia: share price & financials comparison
NSE: PARADEEP vs JUBLINGREA · Chemicals · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Paradeep Phosphates vs Jubilant Ingrevia at a glance
Paradeep Phosphates (PARADEEP) has a market capitalisation of ₹14,582 Cr, against ₹9,325 Cr for Jubilant Ingrevia (JUBLINGREA). Over the past year Jubilant Ingrevia has returned -14.3%, compared with -16.5% for Paradeep Phosphates. Jubilant Ingrevia earns a higher return on equity (10.6% vs 0.0%). Paradeep Phosphates comes out ahead on momentum and technicals. Jubilant Ingrevia comes out ahead on size, profitability, growth and financial health. Across the scored metrics below, Paradeep Phosphates leads on 5 and Jubilant Ingrevia on 9. On StoxGud's 10-point checklist, Paradeep Phosphates scores 4/10 and Jubilant Ingrevia scores 4/10.
| Metric | Paradeep Phosphates | Jubilant Ingrevia |
|---|---|---|
| Size | ||
| Market cap | ₹14,582 Cr | ₹9,325 Cr |
| Revenue (latest FY) | ₹21,826 Cr | ₹4,388 Cr |
| Net profit (latest FY) | ₹0 Cr | ₹278 Cr |
| Valuation | ||
| P/E | — | 26.6 |
| P/B | 2.04 | 2.81 |
| Dividend yield | 0.68% | 0.85% |
| Profitability | ||
| Return on equity | 0.0% | 10.6% |
| Net profit margin | 0.0% | 7.1% |
| Operating margin | 8.6% | 14.2% |
| Growth | ||
| Revenue growth (YoY) | +7.2% | +24.4% |
| Net profit growth (YoY) | — | +60.4% |
| Revenue CAGR (multi-year) | +29.1% | +45.0% |
| Financial health | ||
| Debt to equity | 1.38 | 0.27 |
| Momentum | ||
| 1-month return | -1.0% | -5.7% |
| 1-year return | -16.5% | -14.3% |
| 3-year CAGR | +30.6% | +12.1% |
| 5-year CAGR | — | -1.6% |
| Distance from 52W high | -19.3% | -22.5% |
| Technicals | ||
| RSI (14) | 58 | 47 |
| Price vs 200-day avg | +4.3% | -9.7% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Paradeep Phosphates | Jubilant Ingrevia |
|---|---|---|
| Price above 50-day average | ✗ | ✗ |
| Price above 200-day average | ✓ | ✗ |
| 50-day average above 200-day (uptrend) | ✓ | ✗ |
| RSI in healthy 40–70 zone | ✓ | ✓ |
| Positive 1-year return | ✗ | ✗ |
| Return on equity above 15% | ✗ | ✗ |
| Debt to equity below 1 | ✗ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✗ | ✗ |
| P/E below industry median | ✗ | ✓ |
| Score | 4/10 | 4/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Paradeep Phosphates or Jubilant Ingrevia?
Paradeep Phosphates has a market cap of ₹14,582 Cr and Jubilant Ingrevia has a market cap of ₹9,325 Cr as of 13 Nov 2026.
Which gave better returns in the last year, Paradeep Phosphates or Jubilant Ingrevia?
Jubilant Ingrevia did better: Paradeep Phosphates returned -16.5% and Jubilant Ingrevia returned -14.3% over one year.
What is the difference between Paradeep Phosphates and Jubilant Ingrevia?
Both are NSE-listed companies in Chemicals. Paradeep Phosphates is about 1.6 times the size of Jubilant Ingrevia by market cap. In the latest financial year Paradeep Phosphates reported revenue of ₹21,826 Cr and Jubilant Ingrevia ₹4,388 Cr. Operating margin is 8.6% for Paradeep Phosphates and 14.2% for Jubilant Ingrevia. Debt to equity is 1.38 for Paradeep Phosphates and 0.27 for Jubilant Ingrevia.
Which is better, Paradeep Phosphates or Jubilant Ingrevia?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Paradeep Phosphates leads on 5 and Jubilant Ingrevia on 9. Paradeep Phosphates is ahead on momentum and technicals. Jubilant Ingrevia is ahead on size, profitability, growth and financial health. On StoxGud's rules-based checklist Paradeep Phosphates scores 4/10 and Jubilant Ingrevia scores 4/10. This is information, not advice: consult a SEBI-registered adviser before investing.